39 results on '"Flick-Smith, Helen"'
Search Results
2. Predatory bacteria can protect SKH-1 mice from a lethal plague challenge
3. Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen
4. Assessment of antimicrobial peptide LL-37 as a post-exposure therapy to protect against respiratory tularemia in mice
5. Influence of particle size on the pathology and efficacy of vaccination in a murine model of inhalational anthrax
6. Mechanisms of major histocompatibility complex class II-restricted processing and presentation of the V antigen of Yersinia pestis
7. Enhancement of Insulin-Like Growth Factor I Activity by Novel Antisera: Potential Structure/Function Interactions*
8. Disulfiram, an alcohol dependence therapy, can inhibit the in vitro growth of Francisella tularensis
9. Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles
10. A Bioluminescent Francisella tularensis SCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of Tularemia
11. The Impact of 'Omic' and Imaging Technologies on Assessing the Host Immune Response to Biodefence Agents
12. Bacillus anthracis TIR Domain-Containing Protein Localises to Cellular Microtubule Structures and Induces Autophagy
13. Establishing an In Vivo Imaging Capability in High-Containment
14. Peripheral human γδ T cells control growth of both avirulent and highly virulent strains of Francisella tularensis in vitro
15. Development of a cell targeting vaccine sub-unit delivery system for protection against intracellular pathogens
16. The Designer Proline-rich Antibacterial Peptide A3-APO Prevents Bacillus anthracis Mortality by Deactivating Bacterial Toxins
17. A Toll/interleukin (IL)-1 receptor domain protein from Yersinia pestis interacts with mammalian IL-1/Toll-like receptor pathways but does not play a central role in the virulence of Y. pestis in a mouse model of bubonic plague
18. A Bioluminescent Francisella tularensisSCHU S4 Strain Enables Noninvasive Tracking of Bacterial Dissemination and the Evaluation of Antibiotics in an Inhalational Mouse Model of Tularemia
19. An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor
20. Small protective fragments of the Yersinia pestis V antigen
21. Human Monoclonal Antibodies against Anthrax Lethal Factor and Protective Antigen Act Independently To Protect againstBacillus anthracisInfection and Enhance Endogenous Immunity to Anthrax
22. Immunodominant Francisella tularensis antigens identified using proteome microarray. ©Crown Copyright 2007 Dstl
23. Immunogenicity of a Yersinia pestis Vaccine Antigen Monomerized by Circular Permutation
24. Evaluation of the VP22 protein for enhancement of a DNA vaccine against anthrax
25. Differential Processing of CD4 T-cell Epitopes from the Protective Antigen of Bacillus anthracis
26. Differences in membrane association and sub-cellular distribution between NS2-3 and NS3 of bovine viral diarrhoea virus
27. Characterisation of the immune response to the UK human anthrax vaccine
28. Inhibition of Beta Interferon Transcription by Noncytopathogenic Bovine Viral Diarrhea Virus Is through an Interferon Regulatory Factor 3-Dependent Mechanism
29. Mucosal or Parenteral Administration of Microsphere-Associated Bacillus anthracis Protective Antigen Protects against Anthrax Infection in Mice
30. A Recombinant Carboxy-Terminal Domain of the Protective Antigen of Bacillus anthracis Protects Mice against Anthrax Infection
31. Establishing an In VivoImaging Capability in High-Containment
32. Interactions of bovine viral diarrhoea virus glycoprotein Erns with cell surface glycosaminoglycans
33. Immunodominant Francisella tularensis antigens identified using proteome microarray. ©Crown Copyright 2007 Dstl.
34. Human Monoclonal Antibodies against Anthrax Lethal Factor and Protective Antigen Act Independently To Protect against Bacillus anthracis Infection and Enhance Endogenous Immunity to Anthrax
35. Human Monoclonal Antibodies against Anthrax Lethal Factor and Protective Antigen Act Independently To Protect against Bacillus anthracisInfection and Enhance Endogenous Immunity to Anthrax
36. Immunogenicity of a Yersinia pestisVaccine Antigen Monomerized by Circular Permutation
37. Mucosal or Parenteral Administration of Microsphere-Associated Bacillus anthracisProtective Antigen Protects against Anthrax Infection in Mice
38. A Recombinant Carboxy-Terminal Domain of the Protective Antigen of Bacillus anthracisProtects Mice against Anthrax Infection
39. Layering vaccination with antibiotic therapy results in protection and clearance of Burkholderia pseudomallei in Balb/c mice.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.